ARTICLE | Clinical News
Inhaled insulin: Phase III start
July 25, 2005 7:00 AM UTC
The companies will start next month an open-label,12-month, international Phase III trial in 600 Type I and Type II diabetic patients with mild to moderate asthma or mild to moderate chronic obstructi...